StockData
Inovio Pharmaceuticals, Inc. logo

Inovio Pharmaceuticals, Inc. (INO) stock

INONasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 4/30
$1.69+0.06 (+3.68%)

Close on Nov 18, 2026Market cap $174.74MP/E –Yield –

Inovio Pharmaceuticals price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Inovio Pharmaceuticals's price to sales ratio was 478.9× on Jan 30, 2026, against 231.6× a year earlier. Over the last 5 years it ranged from 10.0× to 478.9×, with a median of 244.8×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Jan 30, 2026478.9×+5.7
2025Oct 31, 2025473.2×+238.9
2024Dec 31, 2024234.4×+73.3
2023Dec 29, 2023161.1×+125.6
2022Dec 30, 202235.5×−125.6
2021Dec 31, 2021161.1×−135.5
2020Apr 30, 2020296.6×+245.0
2019Dec 31, 201951.6×+41.3
2018Dec 31, 201810.3×+1.4
2017Dec 29, 20178.9×−6.8
2016Dec 30, 201615.7×+2.6
2015Dec 31, 201513.1×−43.9
2014Dec 31, 201457.0×+10.2
2013Dec 31, 201346.8×+32.3
2012Dec 31, 201214.5×+5.9
2011Jul 29, 20118.5×–

More Inovio Pharmaceuticals figures

See a number that looks wrong?